EB
EBOS Group Limited
EBOSY · OTC
$23.30 +3.15% (+$0.71)
1M -10.73%
Market Cap $1.68B
P/E Ratio 7.62x
Div. Yield 6.16%
ROE 8.23%
Bulios Fair Price
$32.35
38.8% upside
Trenutna cena
$23.3
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica EBOSY trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
94 /100
Cheap P/FCF 7.89x
P/S 0.13x
P/B 0.61x
Growth
16 /100
Declining Rev. growth 2.51%
FCF growth 12.61%
Book val. growth 4.10%
Profitability
12 /100
Weak Net margin 1.67%
Op. margin 2.80%
FCF margin 1.61%
Quality
42 /100
Average ROE 8.23%
ROA 2.82%
Asset turnover 1.69x
Debt
50 /100
Moderate Current ratio 1.16x
Int. coverage 3.03x
Net debt/EBITDA 3.03x
Stability
74 /100
Stable Rev. volatility 8.66%
EPS volatility 15.10%
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o EBOSY
Online
Sector
Healthcare
Industry
Medical - Distribution
CEO
Adam Luke Hall
Employees
5,700
Headquarters
Docklands